FGF23, a novel muscle biomarker detected in the early stages of ALS

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by progressive muscle weakness. Skeletal muscle is a prime source for biomarker discovery since it is one of the earliest sites to manifest disease pathology. From a prior RNA sequencing project, we identified FGF...

Descripción completa

Detalles Bibliográficos
Autores principales: Si, Ying, Kazamel, Mohamed, Benatar, Michael, Wuu, Joanne, Kwon, Yuri, Kwan, Thaddaeus, Jiang, Nan, Kentrup, Dominik, Faul, Christian, Alesce, Lyndsy, King, Peter H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8187665/
https://www.ncbi.nlm.nih.gov/pubmed/34103575
http://dx.doi.org/10.1038/s41598-021-91496-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8187665/
https://www.ncbi.nlm.nih.gov/pubmed/34103575
http://dx.doi.org/10.1038/s41598-021-91496-6

Ejemplares similares